Role of CA-125 in identification of right ventricular failure in chronic obstructive pulmonary disease

Clinical Cardiology

Volumn 34, Issue 4, 2011, Pages 244-248

  Yilmaz, Mehmet Birhan ^b   Zorlu, Ali ^b   Dogan, Omer Tamer ^a   Karahan, Oguz ^a   Tandogan, Izzet ^b   Akkurt, Ibrahim ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; FEMALE; HEART RIGHT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; MALE; PULMONARY ARTERY; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CA-125 ANTIGEN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HEMODYNAMICS; HUMANS; INPATIENTS; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TURKEY; UP-REGULATION; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT;

EID: 79953687377     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20868     Document Type: Article

References (30)

1. Minas M, Dimitropoulos K, Pastaka C, et al. Global initiative for chronic obstructive lung disease for chronic obstructive pulmonary disease: GOLD opportunity for lung disorders. Prev Med. 2005;40:274-277. (Pubitemid 39468589)
2. Pauwels RA, Buist AS, Ma P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care. 2001;46:798-825.
3. Votto J, Brancifort JM, Scalise PJ, et al. COPD and other diseases in chronically ventilated patients in a prolonged respiratory care unit: a retrospective 20-year survival study. Chest. 1998;113: 86-90. (Pubitemid 28044929)
4. Barnes PJ, Celli BR. Systemicmanifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165-1185.
5. Terzano C, Conti V, Di Stefano F, et al. Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung. 2010;188:321-329.
6. Tayyareci Y, Tayyareci G, Tastan CP, et al. Early diagnosis of right ventricular systolic dysfunction by tissue Doppler-derived isovolumic myocardial acceleration in patients with chronic obstructive pulmonary disease. Echocardiography. 2009;26:1026-1035.
7. Marechal F, Berthiot G, Deltour G. Serum levels of CA-50, CA- 19.9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung. Anticancer Res. 1988;8: 677-680.
8. Bulut I, Arbak P, Coskun A, et al. Comparison of serum CA 19.9, CA 125 and CEA levels with severity of chronic obstructive pulmonary disease. Med Princ Pract. 2009;18:289-293.
9. Yilmaz MB, Zorlu A, Tandogan I. Plasma CA-125 level is related to both sides of the heart: a retrospective analysis. Int J Cardiol. 2009doi:10.1016/j.ijcard.2009.12.003.
10. Colakovic S, Lukic V, Mitrovic L, et al. Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer. Int J Biol Markers. 2000;15:147-152. (Pubitemid 30389362)
11. Bidart JM, Thuillier F, Augereau C, et al. Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring. Clin Chem. 1999;45:1695-1707. (Pubitemid 29477325)
12. Zeimet AG, Offner FA, Marth C, et al. Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells. Anticancer Res. 1997;17:3129-3131. (Pubitemid 27434874)
13. D'Aloia A, Faggiano P, Aurigemma G, et al. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol. 2003;41:1805-1811. (Pubitemid 36584256)
14. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
15. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70:657-662. (Pubitemid 14020664)
16. Milan A, Magnino C, Veglio F. Echocardiographic indexes for the non-invasive evaluation of pulmonary hemodynamics. J Am Soc Echocardiogr. 2010;23:225-239.
17. Galderisi M, Severino S, Cicala S, et al. The usefulness of pulsed tissue Doppler for the clinical assessment of right ventricular function. Ital Heart J. 2002;3:241-247. (Pubitemid 34746655)
18. Saxena N, Rajagopalan N, Edelman K, et al. Tricuspid annular systolic velocity: a useful measurement in determining right ventricular systolic function regardless of pulmonary artery pressures. Echocardiography. 2006;23:750-755. (Pubitemid 44450529)
19. Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:307-332.
20. Lòpez-Candales A, Dohi K, Rajagopalan N, et al. Defining normal variables of right ventricular size and function in pulmonary hypertension: an echocardiographic study. Postgrad Med J. 2008; 84:40-45. (Pubitemid 351236580)
21. Tüller D, Steiner M, Wahl A, et al. Systolic right ventricular function assessment by pulsed wave tissue Doppler imaging of the tricuspid annulus. Swiss Med Wkly. 2005;135:461-468. (Pubitemid 41376649)
22. Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006;174:1034-1041. (Pubitemid 44684453)
23. Refiker M, Yilmaz MB. Association of right heart with CA-125 levels in patients with heart failure. Int J Cardiol. In press.
24. Macnee W. Right heart function in COPD. Semin Respir Crit Care Med. 2010;31:295-312.
25. Klinger JR, Hill NS. Right ventricular dysfunction in chronic obstructive pulmonary disease: evaluation and management. Chest. 1991;99:715-723.
26. Incalzi RA, Fuso L, De Rosa M, et al. Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease. Circulation. 1999;99:1600-1605. (Pubitemid 29152928)
27. Macnee W, Xue QF, Hannan WJ, et al. Assessment by radionuclide angiography of right and left ventricular function in chronic bronchitis and emphysema. Thorax. 1983;38:494-500. (Pubitemid 13030331)
28. Bozkanat E, Tozkoparan E, Baysan O, et al. The significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary disease. J IntMed Res. 2005;33:537-544. (Pubitemid 41388392)
29. Chhabra SK. Pulmonary hypertension associated with chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci. 2010;52:29-40.
30. Han MK, McLaughlin VV, Criner GJ, et al. Pulmonary diseases and the heart. Circulation. 2007;116:2992-3005. (Pubitemid 350291207)